Shipping Famotidine Complete
ALLEGAN — Perrigo Co. this week began shipping store branded Famotidine Complete chewable tablets to customers across the
Perrigo won a patent challenge for Famotidine Complete against Pepcid Complete, which is marketed by Johnson & Johnson — Merck Consumer Pharmaceuticals.
"This is another example of Perrigo's investment in new products that are making quality health care more affordable to American consumers," said President and CEO Joseph C. Papa. "Famotidine Complete is an important new store brand product in the gastrointestinal segment for our retail and wholesale customers and enables them to provide significant savings for the consumer."